Literature DB >> 29492767

Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.

Fu Zhao1,2, Bo Wang3, Zhijun Yang3,4, Qiangyi Zhou3, Peng Li3, Xingchao Wang3, Jing Zhang4, Junting Zhang3, Pinan Liu5,6,7.   

Abstract

Surgical treatment of vestibular schwannoma (VS) in patients with neurofibromatosis type 2 (NF2) along with functional preservation of cranial nerves is challenging. The aim of this study was to analyze the outcomes of hearing and facial nerve function in patients with NF2 who underwent large-size VS (> 2 cm) surgery. From 2006 to 2016, one hundred and forty NF2 patients were included with 149 large-size VS resections using retrosigmoid approach. Hearing function was classified according to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) criteria. Preoperative and one-year postoperative facial nerve function were both assessed using the House-Brackmann (H-B) grading scale. A multivariate logistic regression was performed to identify preoperative predictors for facial function outcomes. No operative death we noted. Total tumor removal was achieved in 82.6% of the operated VSs. The anatomical integrity of the facial nerve was preserved in 67.8% of surgeries. Good facial nerve function (H-B Grades I-III) was maintained in 49.6% of patients at 12 months after surgery. Tumor size larger than 3 cm and preoperative facial weakness related with worse outcome of facial nerve function (P < 0.001; for both). Hearing preservation surgeries were attempted in 31 ears. Class B or C hearing according to the AAO-HNS criteria was maintained in 7 ears (22.5%), and measurable hearing was maintained 11 ears (35.5%). It is challenging to maintain hearing and facial nerve function in NF2 patients with large VSs. Early surgical intervention is an appropriate choice to decrease the risk of neurological functions deficit.

Entities:  

Keywords:  Facial nerve; Hearing preservation; Microsurgery; Neurofibromatosis type 2; Vestibular schwannoma

Mesh:

Year:  2018        PMID: 29492767     DOI: 10.1007/s11060-018-2812-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  36 in total

1.  New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma.

Authors:  Jin Kanzaki; Mirko Tos; Mario Sanna; David A Moffat; Edwin M Monsell; Karen I Berliner
Journal:  Otol Neurotol       Date:  2003-07       Impact factor: 2.311

Review 2.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

3.  Management strategy of vestibular schwannoma in neurofibromatosis type 2.

Authors:  Haitham Ahmad Odat; Enrico Piccirillo; Giuliano Sequino; Abdelkader Taibah; Mario Sanna
Journal:  Otol Neurotol       Date:  2011-09       Impact factor: 2.311

4.  The neuroimaging and clinical spectrum of neurofibromatosis 2.

Authors:  V F Mautner; M Lindenau; M E Baser; W Hazim; M Tatagiba; W Haase; M Samii; R Wais; S M Pulst
Journal:  Neurosurgery       Date:  1996-05       Impact factor: 4.654

5.  Early proactive management of vestibular schwannomas in neurofibromatosis type 2.

Authors:  D E Brackmann; J N Fayad; W H Slattery; R A Friedman; J D Day; W E Hitselberger; R M Owens
Journal:  Neurosurgery       Date:  2001-08       Impact factor: 4.654

6.  Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.

Authors:  M Samii; C Matthies; M Tatagiba
Journal:  Neurosurgery       Date:  1997-04       Impact factor: 4.654

7.  Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.

Authors:  Victor-Felix Mautner; Michael E Baser; Sarang D Thakkar; Urs M Feigen; J M Friedman; Lan Kluwe
Journal:  J Neurosurg       Date:  2002-02       Impact factor: 5.115

8.  Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients.

Authors:  William H Slattery; Laurel M Fisher; William Hitselberger; Rick A Friedman; Derald E Brackmann
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

9.  Hearing preservation in surgery for large vestibular schwannomas.

Authors:  Masahiko Wanibuchi; Takanori Fukushima; John T McElveen; Allan H Friedman
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

10.  Interface between the facial nerve and large acoustic neurinomas. Immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases.

Authors:  J Jääskeläinen; A Paetau; I Pyykkö; G Blomstedt; T Palva; H Troupp
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

View more
  4 in total

1.  Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2.

Authors:  Shi-Wei Li; Jing Zhang; Han-Lu Tang; Peng Li; Bo Wang; Fu Zhao; Pi-Nan Liu
Journal:  J Neurooncol       Date:  2021-11-09       Impact factor: 4.130

2.  [18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.

Authors:  Jose M Anton-Rodriguez; Daniel Lewis; Ibrahim Djoukhadar; David Russell; Peter Julyan; David Coope; Andrew T King; Simon K L Lloyd; D Gareth Evans; Alan Jackson; Julian C Matthews
Journal:  Otol Neurotol       Date:  2019-07       Impact factor: 2.311

3.  Qu-Du-San-Jie decoction induces growth inhibition and vascular normalization in NF2-associated vestibular schwannoma.

Authors:  Jie Lin; Shi-Wei Li; Jing Zhang; Fu-Hao Chu; Cheng-Ze Li; Zhi-Xu Bie; Han-Lu Tang; Shan Gao; Ping Li; Meng-Ting Liao; Tian-Xi Xin; Fu Zhao; Pi-Nan Liu; Xia Ding
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

4.  Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.

Authors:  Qiao Huang; Si-Jia Zhai; Xing-Wei Liao; Yu-Chao Liu; Shi-Hua Yin
Journal:  J Oncol       Date:  2020-07-15       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.